Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Optinose Inc (NQ: OPTN )

4.190 USD -0.050 (-1.18%)
Official Closing Price Updated: 4:23 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Optinose Inc

< Previous 1 2 3 4 5 6 7 8 Next >
8 Stocks Moving In Monday's After-Hours Session
Gainers Yield10 Bioscience, Inc. (NASDAQ: YTEN) shares were up more than 18% following better-than-expected second-quarter ... 
Tags OPTN BE TME
From Benzinga
Optinose Reports Second Quarter 2019 Financial Results and Recent Operational Highlights
From GlobeNewswire News Releases
The Week Ahead In Biotech: Vanda Awaits FDA Decision, BioVie Plans IPO
Biotech stocks came under pressure this week along with the broader market amid an earnings spate. The biggest news break was an FDA ... 
Tags ALT DARE APTX
From Benzinga
Stocks That Fell Through 52-Week Lows Wednesday
On Wednesday, 625 companies set new 52-week lows. Highlights: Industrial And Comml Bank (OTC: IDCBY) was the ... 
Tags RRC AIOSF CAH
From Benzinga
The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks No biotech stocks hit ... 
Tags ANAB DTIL CLLS
From Benzinga
New 52-Week Lows For Monday Morning
Monday's morning session saw 648 companies set new 52-week lows. Areas of Interest: Industrial And Comml ... 
Tags DDAIF SFUN VEGYF
From Benzinga
Stocks That Set New 52-Week Lows Friday Morning
Friday morning, 349 companies reached new 52-week lows. Significant Points: China Construction Bank (OTC: ... 
Tags NINE DT RRBI
From Benzinga
Optinose to Report Second Quarter 2019 Financial Results and Corporate Updates on August 12, 2019
Conference Call and Webcast Scheduled for Monday, August 12 at 4:30 p.m. Eastern Time 
From GlobeNewswire News Releases
Stocks that Reached Yearly Lows Thursday Morning
On Thursday morning, 189 companies achieved new lows for the year. Interesting Highlights: Pfizer (NYSE: PFE) ... 
Tags SLRX TATT NHYKF
From Benzinga
Implied PBSM Analyst Target Price: $31
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags M&A OPTN GRFS
From Benzinga
88 Biggest Movers From Yesterday
Gainers Quad/Graphics, Inc. (NYSE: QUAD) rose 31.2% to close at $11.31 on Wednesday after reporting upbeat Q2 earnings. Enphase ... 
Tags UPL NBSE NANO
From Benzinga
List of Companies Reaching Yearly Lows Tuesday
On Tuesday, 291 companies set new 52-week lows. Interesting Facts: Enbridge (OTC: EBBGF) was the ... 
Tags SCOR SNEC CTRC
From Benzinga
58 Biggest Movers From Yesterday
Gainers Pioneer Bancorp Inc. (NASDAQ: PBFS) shares jumped 47.5% to close at $14.75 o n Thursday. Outlook Therapeutics, Inc. ... 
Tags EXK CHAP APRN
From Benzinga
Optinose to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will... 
From GlobeNewswire News Releases
Optinose Named a 2019 Best Place to Work by Philadelphia Business Journal
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that the Company has been named one of the... 
From GlobeNewswire News Releases
Bargain Bin Stocks: OPTN Now 10.5% Cheaper Than Chief Executive Officer Miller's Buy
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on December 13, OptiNose Inc's Chief Executive Officer,... 
Tags Stocks
From Market News Video
Analysts Forecast 38% Gains Ahead For IBB
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
OptiNose, Inc. (OPTN) Q1 2019 Earnings Call Transcript
OPTN earnings call for the period ending March 31, 2019. 
Tags Market News OPTN
From Motley Fool
The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stock To Debut
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags PRVB RMTI KALA
From Benzinga
Optinose Reports First Quarter 2019 Financial Results and Recent Operational Highlights
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported financial results for the quarter ended March 31,... 
From GlobeNewswire News Releases
OPTN Crosses Above Key Moving Average Level
In trading on Monday, shares of OptiNose Inc (OPTN) crossed above their 200 day moving average of $11.00, changing hands as high as $11.04 per share. OptiNose Inc shares are currently trading up about... 
Tags Stocks
From Market News Video
Optinose to Report First Quarter 2019 Financial Results and Corporate Updates on May 9, 2019
Conference Call and Webcast Scheduled for Thursday, May 9 at 8:00 a.m. Eastern Time 
From GlobeNewswire News Releases
Market Trends Toward New Normal in NIKE, Harley-Davidson, Knowles, Sorrento Therapeutics, OptiNose, and Columbia Sportswear — Emerging Consolidated Expectations, Analyst Ratings
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of NIKE, Inc. (NYSE:NKE),... 
From GlobeNewswire News Releases
PBSM's Holdings Imply 14% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
OptiNose Analysts Projects Prescription Growth In 2019, Beyond
OptiNose Inc (NASDAQ: OPTN) has introduced a new and simplified co-pay assistance program that's led to good script performance, ... 
Tags Market News Reiteration Price Target
From Benzinga
OptiNose, Inc. (OPTN) Q4 2018 Earnings Conference Call Transcript
OPTN earnings call for the period ending December 31, 2018. 
Tags Market News OPTN
From Motley Fool
The Daily Biotech Pulse: Horizon Pharma Under DoJ Radar, FDA Greenlights J&J's Depression Drug, Endologix Reverse Split
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting ... 
Tags Pre/Market Outlook NVAX EVOK
From Benzinga
Optinose Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Operational Highlights
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported financial results for the year ended December 31,... 
From GlobeNewswire News Releases
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs
It was an event-filled one for biotech stocks, with the release of a slew of earnings, presentations of clinical trial results and ... 
Tags FATE JNCE Biotech
From Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.